Literature DB >> 11209966

Brain imaging and the effects of caffeine and nicotine.

S R Dager1, S D Friedman.   

Abstract

Caffeine and nicotine are the most common psychostimulant drugs used worldwide. Structural neuroimaging findings associated with caffeine and nicotine consumption are limited and primarily reflect the putative relationship between smoking and white matter hyperintensities (WMH), a finding that warrants further appraisal of its clinical implications. The application of newer brain imaging modalities that measure subtle haemodynamic changes or tissue-based chemistry in order to better elucidate brain functional processes, including mechanisms underlying addiction to nicotine and caffeine and the brain functional consequences, provide intriguing findings. Potential influences of caffeine and nicotine on the functional contrast, or metabolic response, to neural activation also necessitates the careful appraisal of the effects that these commonly used drugs may have on the results of functional imaging.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11209966     DOI: 10.3109/07853890009002029

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  11 in total

1.  Effects of chronic marijuana use on brain activity during monetary decision-making.

Authors:  Jatin G Vaidya; Robert I Block; Daniel S O'Leary; Laura B Ponto; Mohamed M Ghoneim; Antoine Bechara
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Age Modulates the Association of Caffeine Intake With Cognition and With Gray Matter in Elderly Diabetics.

Authors:  Rebecca K West; Ramit Ravona-Springer; Abigail Livny; Anthony Heymann; Danit Shahar; Derek Leroith; Rachel Preiss; Ruth Zukran; Jeremy M Silverman; Michal Schnaider-Beeri
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-04-23       Impact factor: 6.053

3.  Reduced fronto-cerebellar functional connectivity in chronic alcoholic patients.

Authors:  Baxter P Rogers; Mitchell H Parks; Mark K Nickel; Santosh B Katwal; Peter R Martin
Journal:  Alcohol Clin Exp Res       Date:  2011-11-15       Impact factor: 3.455

Review 4.  Caffeine as an attention enhancer: reviewing existing assumptions.

Authors:  Suzanne J L Einöther; Timo Giesbrecht
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

5.  Caffeine dose effect on activation-induced BOLD and CBF responses.

Authors:  Yufen Chen; Todd B Parrish
Journal:  Neuroimage       Date:  2009-03-13       Impact factor: 6.556

Review 6.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

7.  Relationship between caffeine-induced changes in resting cerebral perfusion and blood oxygenation level-dependent signal.

Authors:  Paul J Laurienti; Aaron S Field; Jonathan H Burdette; Joseph A Maldjian; Yi-Fen Yen; Dixon M Moody
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

8.  A Neurochemical and Electrophysiological Study on the Combined Effects of Caffeine and Nicotine in the Cortex of Rats.

Authors:  Iman M Mourad; Neveen A Noor; Haitham S Mohammed; Heba S Aboul Ezz; Yasser A Khadrawy
Journal:  Basic Clin Neurosci       Date:  2021-09-01

9.  Comparison of brain white matter hyperintensities in methamphetamine and methadone dependent patients and healthy controls.

Authors:  Abdulrasool Alaee; Mehran Zarghami; Samaneh Farnia; Mohammad Khademloo; Talayeh Khoddad
Journal:  Iran J Radiol       Date:  2014-05-15       Impact factor: 0.212

10.  Reliability of quantitative transverse relaxation time mapping with [Formula: see text]-prepared whole brain pCASL.

Authors:  Martin Schidlowski; Rüdiger Stirnberg; Tony Stöcker; Theodor Rüber
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.